Volume 19, Issue 5, 2024
Advanced Strategies of CAR-T Cell Therapy in Solid Tumors and Hematological Malignancies
Pp: 557-572
Author(s): Yangjie Liu, Cao Peng, Faiza Ahad, Syed Aqib Ali Zaidi, Tobias Achu Muluh and Qiuxia Fu*
DOI: 10.2174/0115748928277331231218115402
Published on: 10 January, 2024
Research Progress on the Anticancer Activity of Plant Polysaccharides
Pp: 573-598
Author(s): Qiaoyan Liu, Bo Song, Sen Tong, Qiuqiong Yang, Huanhuan Zhao, Jia Guo, Xuexia Tian, Renjie Chang* and Junzi Wu*
DOI: 10.2174/1574892819666230915103434
Published on: 22 September, 2023
The Clinical Significance and Prognostic Value of ALDH1 Expression in Non-small Cell Lung Cancer: A Systematic Review and Meta-analysis
Pp: 599-609
Author(s): Dong Li, Yu Cao, Cheng-Wen Luo, Li-ping Zhang and Ying-Bo Zou*
DOI: 10.2174/0115748928265992230925053308
Published on: 16 October, 2023
TGF-β Score based on Silico Analysis can Robustly Predict Prognosis and Immunological Characteristics in Lower-grade Glioma: The Evidence from Multicenter Studies
Pp: 610-621
Author(s): Weizhong Zhang, Zhiyuan Yan, Feng Zhao, Qinggui He and Hongbo Xu*
DOI: 10.2174/1574892819666230915143632
Published on: 19 September, 2023
CK2B is a Prognostic Biomarker and a Potential Drug Target for Hepatocellular Carcinoma
Pp: 622-634
Author(s): Huiru Dai, Minling Liu, Yuxi Pan, Tingwei Li, Yihang Pan, Zhe-Sheng Chen, Jing Li*, Yuchen Liu* and Shuo Fang*
DOI: 10.2174/0115748928262221230925090120
Published on: 27 September, 2023
Targeted Regulation of Osteoblasts and Osteoclasts in Osteosarcoma Patients by CSF3R Receptor Inhibition of Osteolysis Caused by Tumor Inflammation Based on Transcriptional Spectrum Analysis and Drug Library Screening
Pp: 635-651
Author(s): Wei Duan, Yu Chen, Jinlu Shan* and Qian Li*
DOI: 10.2174/0115748928259095231010055507
Published on: 18 October, 2023
Upregulation of M6A Reader HNRNPA2B1 Associated with Poor Prognosis and Tumor Progression in Lung Adenocarcinoma
Pp: 652-665
Author(s): Wei Wang and Shengwei Li*
DOI: 10.2174/0115748928258696230925064550
Published on: 17 October, 2023
Fatty Acid Metabolism Signature Contributes to the Molecular Diagnosis of a Malignant Gastric Cancer Subtype with Poor Prognosis and Lower Mutation Burden
Pp: 666-680
Author(s): Zhengwei Chen and Guoxiong Cheng*
DOI: 10.2174/1574892819666230907145036
Published on: 19 September, 2023
Integrating Bioinformatics and Drug Sensitivity Analyses to Identify Molecular Characteristics Associated with Targeting Necroptosis in Breast Cancer and their Clinical Prognostic Significance
Pp: 681-694
Author(s): Chang Zheng, Hanbin Guo, Yongpan Mo and Guowen Liu*
DOI: 10.2174/1574892819666230831112815
Published on: 05 October, 2023
Identification of the Roles of Coagulation-related Signature and its Key Factor RABIF in Hepatoma Cell Malignancy
Pp: 695-710
Author(s): Yanying Chen, Yin Li and Bingyi Zhou*
DOI: 10.2174/1574892819666230829151148
Published on: 26 September, 2023
Patent Selections
Pp: 711-711
DOI: 10.2174/157489281905240528004712
Published on: 27 May, 2024
Acknowledgement to Reviewers
Pp: 712-712
DOI: 10.2174/157489281905240528005310
Published on: 27 May, 2024
